Welcome to LookChem.com Sign In|Join Free
  • or
Home > Products > 28911 > 

28911-01-5

Products Categories

Basic Information
CAS No.: 28911-01-5
Name: Triazolam
Article Data: 19
Molecular Structure:
Molecular Structure of 28911-01-5 (Triazolam)
Formula: C17H12 Cl2 N4
Molecular Weight: 343.215
Synonyms: 4H-s-Triazolo[4,3-a][1,4]benzodiazepine,8-chloro-6-(o-chlorophenyl)-1-methyl- (8CI);8-Chloro-1-methyl-6-(o-chlorophenyl)-4H-s-triazolo[4,3-a][1,4]benzodiazepine; DII-18-2; Halcion; Novodorm; Songar; Triazolam; U 33030
EINECS: 249-307-3
Density: 1.46 g/cm3
Melting Point: 209-212°C
Boiling Point: 535.6 °C at 760 mmHg
Flash Point: 277.7 °C
Solubility: soluble in alcohol and poorly soluble in water.
Appearance: white crystalline powder
Hazard Symbols: ToxicTFlammableF
Risk Codes: 11-23/24/25-36/38-39/23/24/25
Safety: 22-24/25-26-36-45-36/37-16-7
PSA: 43.07000
LogP: 3.66910
  • Display:default sort

    New supplier

This product is a nationally controlled contraband, and the Lookchem platform doesn't provide relevant sales information.

Chemistry

IUPAC Name: 8-Chloro-6-(2-chlorophenyl)-1-methyl-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepine (28911-01-5)
Synonyms : 8-Chloro-6-[2-chlorophenyl]-1-methyl-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepine
Product Categories: Organics;Intermediates & Fine Chemicals;Pharmaceuticals
Molecular Structure:  
Molecular Formula : C17H12Cl2N4
Molecular Weight : 343.21
CAS Registry Number : 28911-01-5
EINECS:  249-307-3
Mol File: 28911-01-5.mol
Surface Tension: 53.4 dyne/cm 
Density: 1.46 g/cm3 
Flash Point: 277.7 °C
Storage temp:  2-8°C 
Enthalpy of Vaporization: 81.21 kJ/mol 
Boiling Point: 535.6 °C at 760 mmHg
Vapour Pressure: 1.51E-11 mmHg at 25°C

Uses

 Triazolam  (28911-01-5) sedative, hypnotic.,controlled Substance.

Toxicity Data With Reference

Organism Test Type Route Reported Dose (Normalized Dose) Effect Source
human TDLo oral 7ug/kg (0.007mg/kg) BRAIN AND COVERINGS: CHANGES IN SURFACE EEG

BEHAVIORAL: SLEEP

BEHAVIORAL: "HALLUCINATIONS, DISTORTED PERCEPTIONS"
Journal of Clinical Pharmacology. Vol. 14, Pg. 102, 1974.
human TDLo oral 29ug/kg (0.029mg/kg) BEHAVIORAL: SLEEP

BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY)

LUNGS, THORAX, OR RESPIRATION: OTHER CHANGES
Gekkan Yakuji. Pharmaceuticals Monthly. Vol. 38, Pg. 2597, 1996.
human TDLo oral 114ug/kg/4D-I (0.114mg/kg) BEHAVIORAL: TOXIC PSYCHOSIS British Medical Journal. Vol. 304, Pg. 1178, 1992.
man TDLo oral 1786ng/kg (0.001786mg/kg) BEHAVIORAL: "HALLUCINATIONS, DISTORTED PERCEPTIONS" Southern Medical Journal. Vol. 80, Pg. 1425, 1987.
man TDLo oral 3289ng/kg (0.003289mg/kg) BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY)

BEHAVIORAL: ALTERATION OF OPERANT CONDITIONING
Clinical Pharmacology and Therapeutics Vol. 49, Pg. 581, 1991.
man TDLo oral 7ug/kg (0.007mg/kg) BEHAVIORAL: COMA

LUNGS, THORAX, OR RESPIRATION: ACUTE PULMONARY EDEMA

LUNGS, THORAX, OR RESPIRATION: RESPIRATORY OBSTRUCTION
Journal of Toxicology, Clinical Toxicology. Vol. 33, Pg. 185, 1995.
man TDLo oral 100ug/kg (0.1mg/kg) BEHAVIORAL: SLEEP

BEHAVIORAL: ATAXIA

CARDIAC: PULSE RATE
Journal of Clinical Psychiatry. Vol. 47, Pg. 50, 1986.
man TDLo oral 107ug/kg (0.107mg/kg) BEHAVIORAL: COMA Archives of Internal Medicine. Vol. 145, Pg. 663, 1985.
man TDLo oral 357ug/kg (0.357mg/kg) BEHAVIORAL: "HALLUCINATIONS, DISTORTED PERCEPTIONS"

BEHAVIORAL: IRRITABILITY

BEHAVIORAL: COMA
Human & Experimental Toxicology. Vol. 11, Pg. 289, 1992.
mouse LD50 intraperitoneal 1625mg/kg (1625mg/kg)   Iyakuhin Kenkyu. Study of Medical Supplies. Vol. 14, Pg. 484, 1983.
mouse LD50 oral 1080mg/kg (1080mg/kg) BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY)

AUTONOMIC NERVOUS SYSTEM: "SMOOTH MUSCLE RELAXANT (MECHANISM UNDEFINED, SPASMOLYTIC)"
Cesko-Slovenska Farmacie. Vol. 37, Pg. 443, 1988.
mouse LD50 subcutaneous > 5gm/kg (5000mg/kg)   Gekkan Yakuji. Pharmaceuticals Monthly. Vol. 25, Pg. 499, 1983.
rat LD50 intraperitoneal > 3300mg/kg (3300mg/kg)   Drugs in Japan Vol. -, Pg. 860, 1995.
rat LD50 oral > 7500mg/kg (7500mg/kg)   Yakkyoku. Pharmacy. Vol. 35, Pg. 1074, 1984.
rat LD50 subcutaneous > 5gm/kg (5000mg/kg)   Gekkan Yakuji. Pharmaceuticals Monthly. Vol. 25, Pg. 499, 1983.
women TDLo oral 100ug/kg (0.1mg/kg) BEHAVIORAL: COMA

LUNGS, THORAX, OR RESPIRATION: CYANOSIS

LUNGS, THORAX, OR RESPIRATION: OTHER CHANGES
American Journal of Emergency Medicine. Vol. 3, Pg. 210, 1985.

Safety Profile

Hazard Codes  F,T
Risk Statements  11-36/38-39/23/24/25
11: Triazolam  (28911-01-5)  is highly Flammable.
36/38:  Irritating to eyes and skin
39/23/24/25:  Toxic: danger of very serious irreversible effects through inhalation, in contact with skin and if swallowed
Safety Statements  22-24/25-26-45-36/37-16-7
7:  Keep container tightly closed
16:  Keep Triazolam (28911-01-5)  away from sources of ignition - No smoking
22:  Do not breathe dust
26:  In case of contact with eyes, rinse immediately with plenty of water and seek medical advice
45:  In case of accident or if you feel unwell, seek medical advice immediately (show label where possible)
24/25:  Avoid contact with skin and eyes
36/37:  Wear suitable protective clothing and gloves
RIDADR  3249
WGK Germany  2
RTECS  XZ5472500
HazardClass  6.1(b)
PackingGroup  III